Filing Details
- Accession Number:
- 0001140361-24-031149
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-24 18:21:08
- Reporting Period:
- 2024-06-20
- Accepted Time:
- 2024-06-24 18:21:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801993 | C. Sean Flynn | 64 Sidney Street Cambridge MA 02139 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-20 | 6,754 | $16.25 | 7,241 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-20 | 6,754 | $45.04 | 487 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-06-21 | 6,772 | $16.25 | 7,259 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-21 | 6,772 | $45.02 | 487 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-06-24 | 1,474 | $16.25 | 1,961 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-24 | 1,474 | $45.84 | 487 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-06-20 | 6,754 | $0.00 | 6,754 | $16.25 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-06-21 | 6,772 | $0.00 | 6,772 | $16.25 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-06-24 | 1,474 | $0.00 | 1,474 | $16.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 123,246 | 2029-11-04 | No | 4 | M | Direct | |
| 116,474 | 2029-11-04 | No | 4 | M | Direct | |
| 115,000 | 2029-11-04 | No | 4 | M | Direct |
Footnotes
- These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
- These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Billionaire Hedge Funds
